Scott Sagel

A champion for advancing diversity in medical research and education, Scott D. Sagel is a distinguished Professor in the Department of SOM-PEDS at the University of Colorado Denver - Anschutz Medical Campus. With a robust academic background, Dr. Sagel earned his MD from the prestigious Harvard Medical School. He further honed his expertise in pediatrics through a residency and fellowship in pediatric pulmonary medicine at Children's Hospital Boston, where he developed a keen interest in cystic fibrosis. Dr. Sagel's research is primarily centered on noninvasive biomarkers of proteolytic activity in cystic fibrosis, a field in which he has made significant contributions. As the Principal Investigator on an NIH-funded grant (K23RR018611), he is at the forefront of studying innovative approaches to understanding and treating this complex condition. His work has been widely recognized, with numerous publications in esteemed peer-reviewed journals, reflecting his commitment to advancing knowledge and improving patient outcomes. In addition to his research endeavors, Dr. Sagel is an active member of several professional organizations, where he collaborates with fellow experts to push the boundaries of pediatric pulmonary medicine. His dedication to his field is matched by his passion for mentoring the next generation of medical professionals, fostering an inclusive and dynamic learning environment. Dr. Sagel's contributions extend beyond his research and teaching, as he is deeply involved in initiatives aimed at enhancing diversity within the medical community. His efforts have not only enriched the academic landscape but have also paved the way for more equitable healthcare solutions. Through his work, Dr. Sagel continues to inspire both his colleagues and students, leaving a lasting impact on the field of cystic fibrosis research and beyond.